Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04676243
Status:
WITHDRAWN
Last Update Posted:
2022-05-25
First Post:
2020-12-09
Brief Title:
Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physicians Choice in Newly Diagnosed FLT3-ITD AML
Sponsor:
University Hospital Heidelberg
Organization:
University Hospital Heidelberg
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-09
First Submit QC Date:
December 15 2020
Study First Post Date:
2020-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-18
Last Update Post Date:
2022-05-25
Last Update Post Date Type:
ACTUAL